Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
 

Search in our Online Store

R&D Collaborations
Filter     Order     Display # 
Date Item Title
10 Oct 2006 Crucell Secures $16.2 million NIH Contract for HIV Vaccine Design and Developmen
06 Oct 2006 Dyax Corp. Announces Funded Research Agreement with Trubion Pharmaceuticals Inc. for Discovery of Therapeutic Proteins
04 Oct 2006 InNexus Biotechnology Announces Collaboration Focused on Developing Novel Antiviral Antibodies
03 Oct 2006 GTC Biotherapeutics And LFB Biotechnologies Enter Strategic Collaboration For Recombinant Plasma Proteins And Monoclonal Antibodies
03 Oct 2006 Plexxikon and Servier Signed Cardiovascular Collaboration
03 Oct 2006 XOMA and Affimed Sign Antibody Cross-License and Collaboration Agreement
02 Oct 2006 Oxford Biomedica Expands Its Ocular Programme Through Collaboration And Investment Led By The Foundation Fighting Blindness
30 Sep 2006 Sanofi Pasteur and the Pediatric Dengue Vaccine Initiative Partner Against Dengue Fever
29 Sep 2006 Pharmacopeia and Schering-Plough Extend Collaboration
29 Sep 2006 Alnylam Awarded $23 Million U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats
28 Sep 2006 Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
28 Sep 2006 Arena Pharmaceuticals, Inc. Announces That Ortho-McNeil Pharmaceutical, Inc. Extends Research Term Under Partnership To Develop Drugs To Treat Type 2 Diabetes
28 Sep 2006 InNexus Enters R&D Agreement Targeting Cancer with BioInvent of Sweden; Appoints New Chairman of the Board of Directors
22 Sep 2006 Trophos SA and CHDI, Inc. extend partnership to develop promising compounds in models relevant to Huntington disease
21 Sep 2006 Biogen Idec and Alnylam Form Alliance to Discover and Develop Therapeutics for the Potential Treatment of Progressive Multifocal Leukoencephalopathy (PML); Collaboration to Focus on RNAi Therapeutics Targeting the JC Virus
20 Sep 2006 Organon and Schering AG to continue research in male fertility control separately
14 Sep 2006 Transition Therapeutics Inc. and JDRF Announce Partnership to Develop Diabetes Regenerative Product GLP1-I.N.T.(TM)
12 Sep 2006 Affinergy Signs Exclusive Development & License Agreement with Synthes
12 Sep 2006 EnBioTec and TimTec have entered into an agreement to develop nuclear receptor based lead chemicals
08 Sep 2006 Trimeris Extends Research Agreement with Roche Covering Next-Generation HIV Fusion Inhibitors; Research Term Extended for Additional 2 Years Through the End of 2008; TRI-1144 Advancing as the Lead Preclinical Candidate
07 Sep 2006 Graffinity and Boehringer Ingelheim Pharmaceuticals Enter into Drug Discovery Research Agreement
07 Sep 2006 Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
06 Sep 2006 GNI Ltd. and the University of Auckland's UniServices Ltd. Announce Collaboration
06 Sep 2006 Galapagos and OneWorld Health collaborate
06 Sep 2006 Collaboration with PATH for the development of Intercell’s Streptococcus pneumoniae vaccine
06 Sep 2006 Odyssey Thera, Inc. Announces A Major Multi-Year Collaboration With Pfizer Inc
05 Sep 2006 Cancer Research Technology Announce Colorectal Cancer Research Collaboration with AstraZeneca
01 Sep 2006 ImmunoGen, Inc. Announces that sanofi-aventis Has Extended the Term of its Research Collaboration with the Company; ImmunoGen Also Gains More Flexibility to Expand Product Pipeline
31 Aug 2006 Immunetrics Inc. Extends In Silico Modeling Collaboration With Lilly
31 Aug 2006 PDL BioPharma Announces Roche Discontinuation of Co-Development of Daclizumab in Asthma
27 Aug 2006 Olympus Expands Investment, Partnership with Cytori Therapeutics in Regenerative Medecine
25 Aug 2006 GlaxoSmithKline and ChemoCentryx Enter Into Drug Discovery and Development Alliance in Inflammatory Disorders
24 Aug 2006 PrimeCell(TM) Therapeutics Partners with Regeneration Technologies, Inc. to Co-Develop Stem Cell Product for Orthopedic Applications
23 Aug 2006 Fresenius Kabi and Sandoz to cooperate in the development of an HESylated biopharmaceutical drug
23 Aug 2006 Entelos, Inc. Announces Research Collaboration With Novartis Pharma AG
23 Aug 2006 Medarex and GenPat77 Announce Therapeutic Antibody Co-Development Agreement
18 Aug 2006 Xenogen Biosciences Announces Target Validation Collaboration Agreement With Schering-Plough Corporation
17 Aug 2006 Algeta and Affibody Initiate Anticancer Targeted Therapy Collaboration
10 Aug 2006 CHDI Selects Evotec as Strategic Drug Discovery Partner in the Search for Huntington Disease Treatments
08 Aug 2006 Genstruct Extends Collaboration in Cancer with GlaxoSmithKline
07 Aug 2006 Geron, University of Edinburgh Form Collaboration for Development of Three Cell Types Derived From Human Embryonic Stem Cells
07 Aug 2006 Epigenomics AG Enters into Agreement with Johnson & Johnson Pharmaceutical Researach & Development, L.L.C
04 Aug 2006 Amorfix Life Sciences and Biogen Idec to collaborate on research for ALS disease
03 Aug 2006 Galapagos announces new collaboration with AstraZeneca
02 Aug 2006 CHDI and Edison Enter Collaborative Agreement; Development of Therapeutics Targeting Huntington's Disease
31 Jul 2006 Phyton Biotech Signs Development Agreement With Insmed
31 Jul 2006 Predix Pharmaceuticals Announces Collaboration for Development of S1P1 Modulators for the Treatment of Autoimmune Diseases
26 Jul 2006 Avalon and ChemDiv to Collaborate in Oncology Drug Discovery and Development
26 Jul 2006 Sandoz Signs Exclusive Collaboration with Momenta Pharmaceuticals to Develop Complex Generics and Follow-on Biotechnology Drugs
25 Jul 2006 GNI Affiliate Shanghai Genomics Announces New Collaboration on Drug Discovery Project; Shanghai Genomics Adds Centocor, Inc. to a Growing List of International Research Partners
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 530

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics